COVID-19 Stroke Apical Lung Examination Study
1 other identifier
observational
2,000
1 country
12
Brief Summary
Multi-centre prospective study evaluating computed tomography angiography studies performed for stroke patients as a diagnostic and prognostic imaging biomarker.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2020
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2020
CompletedFirst Submitted
Initial submission to the registry
November 20, 2020
CompletedFirst Posted
Study publicly available on registry
November 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2021
CompletedMay 27, 2021
May 1, 2021
1.3 years
November 20, 2020
May 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of the computed tomography angiography biomarker relative to the COVID-19 RT-PCR test
Defined by sensitivity, specificity, positive and negative predictive values
1 month
Secondary Outcomes (1)
Prognostic value of the computed tomography biomarker
1 month
Eligibility Criteria
All adult patients presenting to participating centres with clinical features of acute ischaemic stroke undergoing investigation with computed tomography angiography at presentation.
You may qualify if:
- All adult patients presenting with clinical features of acute ischaemic stroke undergoing investigation with computed tomography angiography at presentation.
You may not qualify if:
- Poor image quality. No radiologist report available. Computed tomography angiography performed in a non-acute setting.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
Royal United Hospitals Bath NHS Foundation Trust
Bath, United Kingdom
North Bristol NHS Trust
Bristol, United Kingdom
University Hospitals Bristol NHS Foundation Trust
Bristol, United Kingdom
Frimley Health NHS Foundation Trust
Camberley, United Kingdom
Cardiff and Vale University Health Board
Cardiff, United Kingdom
University Hospitals Coventry and Warwickshire NHS Trust
Coventry, United Kingdom
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Imperial College Healthcare NHS Foundation Trust
London, United Kingdom
King's College Hospital NHS FT (KCH)
London, United Kingdom
King's College Hospital NHS FT (PRUH)
London, United Kingdom
University College London NHS Foundation Trust
London, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2020
First Posted
November 23, 2020
Study Start
July 10, 2020
Primary Completion
October 31, 2021
Study Completion
October 31, 2021
Last Updated
May 27, 2021
Record last verified: 2021-05